Science-Backed How Tirzepatide works Tirzepatide is a first-in-class dual-agonist, activating both GLP-1 and GIP hormone receptors to powerfully regulate appetite, blood sugar, and fat metabolism
A phase 3 trial to test the benefits of melatonin treatment in association with hypothermia in infants with HIE was withdrawn prior to enrollment in 2015 (NCT01904786)
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis
Meet with your specialist to review your health history, goals, and lab results
Our healthcare professionals work closely with you to develop a customized treatment plan that aligns with your specific needs and goals
For providers who are prescribing these medications, it is important to properly counsel patients to manage their weight loss